SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000904454-16-001143
Filing Date
2016-03-22
Accepted
2016-03-22 16:51:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D BY ARGOS THERAPEUTICS, INC. BY PHARMSTANDARD INTERNATIONAL S.A. s13d_032216-argos.htm SC 13D 104811
  Complete submission text file 0000904454-16-001143.txt   106317
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88006 | Film No.: 161521524
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13D